SynopsisIL-1R agonists refer to a class of compounds or molecules that activate the interleukin-1 receptor (IL-1R). IL-1R is a cell surface receptor that, after binding to IL-1 and other cytokines, can initiate a series of signaling pathways and participate in regulat.....
SynopsisThe global Health Monitoring Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. According to our research, the global market for medical devices i.....
SynopsisCell Isolation/Cell Separation is the ability to separate cells according to their properties. The tissue material is dispersed into a cell suspension to obtain the target cells. Cell separation technologies refer to isolation of target cells from a mixture of.....
SynopsisTrack and trace solutions are an essential part of this strategy. Track and trace solutions identify the origins of a pharmaceutical industry product and verify its authenticity. Moreover, track and trace solutions also help combat product diversion, whereby l.....
SynopsisAssistive technology for the visually impaired refers to a range of devices, software, and tools designed to enhance the independence, accessibility, and overall quality of life for individuals with visual impairments or blindness. These technologies aim to co.....
SynopsisChronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow. The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, me.....
SynopsisThe global Medical Simulation Education market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. According to our research, the global market for medical device.....
SynopsisFavipiravir, sold under the brand name Avigan, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections. Like the experimental antiviral drugs (T-1105 and T-1106), it is a pyrazinecarboxa.....
SynopsisThe global Short Bowel Syndrome Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Short Bowel Syndrome Drugs in various end use industries. The e.....
SynopsisThe global Chlamydia Infection Diagnostics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Chlamydia Infection Diagnostics in various end use industr.....
